1. Brawley, O.W., Knopf, K., and Merrill, R. (1998) The epidemiology of prostate cancer part I: descriptive epidemiology. Seminars in Urologic Oncology, 16, 187–192.
2. Schroder, F.H. (1999) Endocrine treatment of prostate cancer — recent developments and the future. Part 1: maximal androgen blockade, early vs delayed endocrine treatment and side-effects. BJU International, 83, 161–170.
3. Johansson, J.E., Adami, H.O., Andersson, S.O., Bergstrom, R., Krusemo, U.B., and Kraaz, W. (1989) Natural history of localised prostatic cancer. A population-based study in 223 untreated patients. Lancet, 1, 799–803.
4. Breslow, N., Chan, C.W., Dhom, G., Drury, R.A., Franks, L.M, Gellei, B., Lee, Y.S., Lundberg, S., Sparke, B., Sternby, N.H., and Tulinius, H. (1977) Latent carcinoma of prostate of autopsy in seven areas. International Journal of Cancer, 20, 680–688.
5. Shiraishi, T., Watanabe, M, Matsuura, H., Kusano, I., Yatani, R., and Stemmermann, G.N. (1994) The frequency of latent prostatic carcinoma in young males: the Japanese experience. In Vivo, 8, 445–447.